Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients

Clinical trial NCT06900088 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06900088
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia

Start date: 2025-04-25
Primary completion: 2025-10-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.